Edition:
United Kingdom

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

21.60CNY
14 Dec 2017
Change (% chg)

¥-0.21 (-0.96%)
Prev Close
¥21.81
Open
¥21.79
Day's High
¥21.79
Day's Low
¥21.47
Volume
7,993,522
Avg. Vol
19,554,165
52-wk High
¥23.90
52-wk Low
¥16.95

Latest Key Developments (Source: Significant Developments)

Kangmei Pharmaceutical to invest 47.5 mln yuan to set up genetic tech JV in Shenzhen
Friday, 8 Dec 2017 

Dec 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 47.5 million yuan to set up a genetic technology JV with BGI Genomics Co Ltd <<<300676.SZ>>>, with registered capital of 50 million yuan, in Shenzhen .Says the company will hold a 95 percent stake in the JV .  Full Article

Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan
Sunday, 3 Dec 2017 

Dec 3(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years .  Full Article

Kangmei Pharmaceutical signs strategic cooperation agreement with local government
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it signs strategic cooperation agreement with local government of Dingxi city, Gansu province.Says two entities will cooperate on medicine related business .  Full Article

Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan
Wednesday, 8 Nov 2017 

Nov 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years.  Full Article

Kangmei Pharmaceutical to sell 100 pct stake in Weihai-based bioengineering firm for 2.2 mln yuan
Monday, 30 Oct 2017 

Oct 30(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it plans to sell 100 percent stake in a Weihai-based bioengineering firm for 2.2 million yuan .  Full Article

Kangmei Pharmaceutical's 9-month profit up, to invest in three units and acquire a firm
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says 9-month net profit up 21.6 percent y/y.Says it plans to invest 160 million yuan ($24.05 million) to set up three units.Says it plans to acquire pharmaceutical firm for up to 140 million yuan.  Full Article

Kangmei Pharmaceutical issues debentures worth 2.5 bln yuan
Tuesday, 1 Nov 2016 

Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it issued 2016 first tranche super short-term debentures worth 2.5 billion yuan with a term of 365 days and interest rate of 3.28 percent.  Full Article

Kangmei Pharma to set up units
Monday, 31 Oct 2016 

Kangmei Pharmaceutical <600518.SS> : Says it will invest 50 million yuan to set up a wholly owned unit in Yunnan, unit to be engaged in planting and sale of seeds and seedlings .Says one unit to set up a new unit in Jilin, for hospital operation and management.  Full Article

Kangmei Pharma's 9-mth net profit rises 23 pct y/y
Sunday, 30 Oct 2016 

Kangmei Pharmaceutical Co Ltd <600518.SS> :Says 9-month net profit up 23.0 percent y/y.  Full Article

Kangmei Pharma's unit buys 60 pct stake in hospital operator for 394.8 mln yuan
Friday, 14 Oct 2016 

Kangmei Pharmaceutical Co Ltd <600518.SS> :Says unit buys 60 percent stake in hospital operator for 394.8 million yuan ($59.20 million).  Full Article

BRIEF-Kangmei Pharmaceutical to invest 47.5 mln yuan to set up genetic tech JV in Shenzhen

* Says it plans to invest 47.5 million yuan to set up a genetic technology JV with BGI Genomics Co Ltd, with registered capital of 50 million yuan, in Shenzhen